Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer

Oncology Reports

Volumn 21, Issue 6, 2009, Pages 1599-1604

  Ribeiro, Fabiana S ^a,b   Simão, Tatiana A ^a   Amoêdo, Nivea D ^b   Andreollo, Nelson A ^c   Lopes, Luiz Roberto ^c   Acatauassu, Rodolfo ^d   Rumjanek, Franklin D ^b   Albano, Rodolpho M ^a   Pinto, Luis Felipe R ^a   Monteiro, Robson Q ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Clotting initiator tissue factor; Esophageal squamous cell carcinoma; Interleukin 8; Protease activated receptor 1

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; RNA; THROMBOPLASTIN; IL8 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; BRAZIL; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; MIDDLE AGED; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; RECEPTOR, PAR-1; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 67649935018     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000393     Document Type: Article

References (38)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 206.
2. Ribeiro Pinto LF, Teixeira Rossini AM, Albano RM, Felzenszwalb I, De Moura Gallo CV, Nunes RA and Andreollo NA: Mechanisms of esophageal cancer development in Brazilians. Mutat Res 544: 365-373, 2003.
3. Allen JW, Richardson JD and Edwards MJ: Squamous cell carcinoma of the esophagus: a review and update. Surg Oncol 6: 193-200, 1997.
4. Vizcaino AP, Moreno V, Lambert R, et al: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99: 860-868, 2002.
5. Enzinger PC and Mayer RJ: Medical progress: esophageal cancer. N Engl J Med 349: 2241-2252, 2003.
6. Law S and Wong J: The current management of esophageal cancer. Adv Surg 41: 93-119, 2007.
7. Varki A: Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729, 2007.
8. Rak J, Milsom C, May L, Klement P and Yu J: Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost 32: 54-70, 2006.
9. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S and Williamson RC: Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 82: 1101-1104, 1995.
10. Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, Nakamura S and Shiku H: Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69: 247-254, 2002.
11. Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K and Yoshizawa Y: Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79: 472-477, 1999.
12. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST and Wong J: Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 9: 5339-5345, 2003.
13. Ossovskaya VS and Bunnett NW: Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621, 2004.
14. Rao LV and Pendurthi UR: Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 25: 47-56, 2005.
15. Belting M, Ahamed J and Ruf W: Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 25: 1545-1550, 2005.
16. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I and Bar-Shavit R: Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4: 909-914, 1998.
17. Liu Y, Gilcrease MZ, Henderson Y, Yuan XH, Clayman GL and Chen Z: Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett 169: 173-180, 2001.
18. Darmoul D, Gratio V, Devaud H, Lehy T and Laburthe M: Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162: 1503-1513, 2003.
19. Ikeda O, Egami H, Ishiko T, Ishikawa S, Kamohara H, Hidaka H, Mita S and Ogawa M: Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis. Int J Oncol 22: 295-300, 2003.
20. Simão TA, Simões GL, Ribeiro FS, Cidade DA, Andreollo NA, Lopes LR, Macedo JM, Acatauassu R, Teixeira AM, Felzenszwalb I, Pinto LF and Albano RM: Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas. Hum Exp Toxicol 25: 515-522, 2006.
21. Robottom Ferreira AB, Ribeiro Pinto LF and Albano RM: An optimized reverse transcription-polymerase chain reaction procedure for the amplification of low-copy Cyp2a3 mRNA in rat esophagus. Anal Biochem 319: 323-326, 2003.
22. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
23. Gomez K and McVey JH: Tissue factor initiated blood coagulation. Front Biosci 11: 1349-1359, 2006.
24. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M and Nemerson Y: Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9: 458-462, 2003.
25. Signaevsky M, Hobbs J, Doll J, Liu N and Soff GA: Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost 34: 161-169, 2008.
26. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Konieczny D, Kustrzeba-Wojcicka I, Terlecki G and Banas T: Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas - implication for clinical evaluation of cancer patient. Cytokine 41: 232-239, 2008.
27. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK, Pendurthi UR and Rao LV: Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 103: 3029-3037, 2004.
28. Liu J, Schuff-Werner P and Steiner M: Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 343: 183-189, 2006.
29. Lip GY, Chin BS and Blann AD: Cancer and the prothrombotic state. Lancet Oncol 3: 27-34, 2002.
30. White RH, Chew H and Wun T: Targeting patients for anticoagulant prophylaxis trials in patients with cancer: Who is at highest risk? Thromb Res 120 (S2): 29-40, 2007.
31. Depasquale I and Thompson WD: Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. Histopathology 52: 500-509, 2008.
32. Kitadai Y, Onogawa S, Kuwai T, Matsumura S, Hamada H, Ito M, Tanaka S, Yoshihara M and Chayama K: Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 11: 315-319, 2004.
33. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S and Müller W: VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 9: 995-999, 2002.
34. Möbius C, Freire J, Becker I, Feith M, Brücher BL, Hennig M, Siewert JR and Stein HJ: VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg 31: 1768-1774, 2007.
35. Yin YJ, Salah Z, Maoz M, Ram SC, Ochayon S, Neufeld G, Katzav S and Bar-Shavit R: Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J 17: 163-174, 2003.
36. Yuan A, Chen JJ, Yao PL and Yang PC: The role of interleukin-8 in cancer cells and microenvironment interaction Front Biosci 10: 853-865, 2005.
37. Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP and Belperio JA: Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42: 768-778, 2006.
38. Francischetti IM, Seydel KB and Monteiro RQ: Blood coagulation, inflammation, and malaria. Microcirculation 15: 81-107, 2008.